Compare
Neogen vs West Pharmaceutical Services (NEOG vs WST)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Neogen (NEOG) returned +89.4% and West Pharmaceutical Services (WST) +41.0%; so far this year the figures are +68.2% and +45.3%.
West Pharmaceutical Services is the larger company by market value, about 10.8 times the size of Neogen.
Revenue grew -0.3% at NEOG and +12.6% at WST over the last year.
NEOG pays no dividend. WST yields 0.22%.
Data as of the latest close. Not investment advice.
Relative performance
| NEOG | WST | |
|---|---|---|
| Price | $11.76 | $399.81 |
| 1-day | +0.68% | +1.87% |
| YTD | +68.24% | +45.31% |
| 1 year | +89.37% | +41.01% |
| 3 years | -20.38% | +24.29% |
| Market cap | $2.6B | $27.9B |
| P/E | — | 44.9 |
| P/S | 2.90 | 8.20 |
| P/B | 1.23 | 9.38 |
| Revenue growth | -0.30% | +12.60% |
| EPS growth | — | +32.00% |
| Gross margin % | 47.4 | 37.6 |
| Net margin % | -6.3 | 18.8 |
| ROE % | -2.7 | 21.5 |
| Debt / equity | 0.74 | 0.07 |
| FCF yield % | 1.9 | 1.6 |
| Dividend yield % | — | 0.22 |
| Beta | 1.41 | 0.66 |
| RSI (14) | 45.5 | 57.5 |
| Technical rating |